Table 1.
Characteristic | Q1 (≤ 12 μg/L) | Q2 (12–62 μg/L) | Q3 (62–148 μg/L) | Q4 (> 148 μg/L) | p-Valuea | ||||
---|---|---|---|---|---|---|---|---|---|
No. | Mean ± SD or % | No. | Mean ± SD or % | No. | Mean ± SD or % | No. | Mean ± SD or % | ||
Age (years) | 2,752 | 36.9 ± 10.0 | 2,711 | 36.6 ± 10.0 | 2,688 | 36.6 ± 9.9 | 2,702 | 37.0 ± 10.0 | 0.234 |
Male (%) | 1,170 | 42.5 | 1,143 | 42.2 | 1,124 | 41.8 | 1,151 | 42.6 | 0.935 |
Current smoker (%) | 813 | 29.6 | 792 | 29.2 | 747 | 27.8 | 751 | 27.8 | 0.334 |
Diabetes history (%) | 55 | 2.0 | 59 | 2.2 | 46 | 1.7 | 43 | 1.6 | 0.370 |
Education (years) | 2,750 | 3.6 ± 3.9 | 2,710 | 3.2 ± 3.7 | 2,687 | 3.5 ± 3.9 | 2,700 | 3.3 ± 3.7 | 0.002 |
BMI baseline (kg/m2) | 2,730 | 19.9 ± 3.3 | 2,701 | 19.7 ± 3.1 | 2,670 | 19.7 ± 3.0 | 2,690 | 19.4 ± 3.0 | < 0.001 |
Systolic blood pressure (mmHg) | |||||||||
Baseline | 2,752 | 113.6 ± 16.6 | 2,711 | 114.7 ± 17.2 | 2,688 | 113.6 ± 16.5 | 2,702 | 113.5 ± 16.6 | 0.391 |
Follow up 1 | 2,676 | 113.9 ± 16.8 | 2,639 | 113.7 ± 17.0 | 2,623 | 113.5 ± 17.1 | 2,639 | 114.2 ± 17.4 | 0.442 |
Follow up 2 | 2,557 | 118.4 ± 15.6 | 2,475 | 117.8 ± 15.3 | 2,492 | 117.8 ± 15.5 | 2,489 | 117.4 ± 15.2 | 0.175 |
Follow up 3 | 2,432 | 108.5 ± 14.9 | 2,399 | 112.6 ± 14.8 | 2,366 | 112.6 ± 15.7 | 2,356 | 112.0 ± 15.6 | < 0.001 |
Diastolic blood pressure (mmHg) | |||||||||
Baseline | 2,750 | 73.8 ± 11.5 | 2,711 | 73.6 ± 11.3 | 2,685 | 73.4 ± 11.1 | 2,700 | 73.1 ± 11.5 | 0.132 |
Follow up 1 | 2,677 | 73.0 ± 10.2 | 2,638 | 72.8 ± 10.3 | 2,623 | 72.6 ± 10.2 | 2,639 | 72.9 ± 10.3 | 0.557 |
Follow up 2 | 2,557 | 76.3 ± 10.3 | 2,475 | 76.2 ± 10.0 | 2,492 | 76.1 ± 10.0 | 2,489 | 76.0 ± 10.1 | 0.683 |
Follow up 3 | 2,432 | 71.1 ± 9.9 | 2,399 | 73.9 ± 10.0 | 2,366 | 73.8 ± 10.2 | 2,356 | 73.4 ± 10.1 | < 0.001 |
Urinary arsenic (μg/L) | |||||||||
Baseline | 2,711 | 51.0 ± 47.7 | 2,662 | 99.2 ± 79.3 | 2,576 | 150.9 ± 120.4 | 2,600 | 258.2 ± 233.8 | < 0.001 |
Follow up 1 | 2,671 | 54.3 ± 57.7 | 2,633 | 106.9 ± 87.5 | 2,625 | 145.3 ± 133.8 | 2,629 | 185.7 ± 199.1 | < 0.001 |
Follow up 2 | 2,621 | 54.7 ± 55.6 | 2,534 | 105.7 ± 85.5 | 2,547 | 139.1 ± 125.6 | 2,542 | 178.5 ± 191.4 | < 0.001 |
Follow up 3 | 2,564 | 51.6 ± 57.5 | 2,510 | 92.8 ± 77.7 | 2,499 | 118.6 ± 108.8 | 2,484 | 149.2 ± 169.5 | < 0.001 |
Urinary creatinine-adjusted arsenic (μg/g creatinine) | |||||||||
Baseline | 2,711 | 99.8 ± 83.5 | 2,662 | 209.1 ± 151.7 | 2,576 | 316.8 ± 200.5 | 2,600 | 525.8 ± 488.1 | < 0.001 |
Follow up 1 | 2,671 | 96.7 ± 74.4 | 2,633 | 193.1 ± 121.8 | 2,625 | 264.2 ± 213.6 | 2,629 | 344.9 ± 326.7 | < 0.001 |
Follow up 2 | 2,621 | 98.5 ± 79.4 | 2,534 | 198.0 ± 120.6 | 2,547 | 259.2 ± 201.1 | 2,542 | 333.1 ± 323.1 | < 0.001 |
Follow up 3 | 2,564 | 99.0 ± 89.5 | 2,510 | 190.2 ± 153.6 | 2,499 | 247.8 ± 191.2 | 2,484 | 305.1 ± 309.7 | < 0.001 |
Abbreviations: Q1, quartile 1; Q2, quartile 2; Q3, quartile 3; Q4, quartile 4. Q1: median = 2.3, SD = 3.3, range = 11.9; Q2: median = 34.0, SD = 14.4, range = 49.7; Q3: median = 101.0, SD = 25.2, range = 86.0; Q4: median = 239.0, SD = 107.4, range = 714.0.aRepresents the global difference and is based on the chi-square test for categorical variables and analysis of variance for continuous variables. |